DrugPatentWatch Database Preview
Drugs in MeSH Category Angiotensin II Type 1 Receptor Blockers
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | DIOVAN | valsartan | CAPSULE;ORAL | 020665-001 | Dec 23, 1996 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Qilu Pharm Co Ltd | OLMESARTAN MEDOXOMIL | olmesartan medoxomil | TABLET;ORAL | 210552-002 | Jan 10, 2019 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Mylan | VALSARTAN | valsartan | TABLET;ORAL | 090866-004 | Jan 5, 2015 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Sunshine Lake | OLMESARTAN MEDOXOMIL | olmesartan medoxomil | TABLET;ORAL | 211049-003 | Feb 22, 2019 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Ivax Pharms | VALSARTAN | valsartan | TABLET;ORAL | 077530-002 | Jan 4, 2016 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
